Literature DB >> 12910257

Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation.

Frauke Fehrmann1, Laimonis A Laimins.   

Abstract

Human papillomavirus (HPV) infections play a crucial role in the pathogenesis of cervical neoplasia. Insights into the mechanisms by which HPV infection can, in a small numbers of cases, result in malignancy, comes from the observation that three proteins encoded by high-risk genital HPVs, E6, E7 and to a lesser extent E5, target factors that control the cell cycle and proliferation. These interactions result in abrogation of cell cycle control, chromosomal alterations, telomerase activation, and eventual cell immortalization. In this review, we discuss the functions of E6, E7, and E5 proteins that are most relevant to the malignant progression of HPV-transformed cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12910257     DOI: 10.1038/sj.onc.1206554

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  71 in total

1.  The human papillomavirus type 16 E5 oncoprotein inhibits epidermal growth factor trafficking independently of endosome acidification.

Authors:  Frank A Suprynowicz; Ewa Krawczyk; Jess D Hebert; Sawali R Sudarshan; Vera Simic; Christopher M Kamonjoh; Richard Schlegel
Journal:  J Virol       Date:  2010-08-04       Impact factor: 5.103

Review 2.  Vaccination against human papilloma virus (HPV): epidemiological evidence of HPV in non-genital cancers.

Authors:  Ioannis N Mammas; George Sourvinos; Apostolos Zaravinos; Demetrios A Spandidos
Journal:  Pathol Oncol Res       Date:  2010-07-18       Impact factor: 3.201

3.  Membrane orientation of the human papillomavirus type 16 E5 oncoprotein.

Authors:  Ewa Krawczyk; Frank A Suprynowicz; Sawali R Sudarshan; Richard Schlegel
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

4.  Phylogenetic incongruence among oncogenic genital alpha human papillomaviruses.

Authors:  Apurva Narechania; Zigui Chen; Rob DeSalle; Robert D Burk
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

5.  HPV16 E6*II gene expression in intraepithelial cervical lesions as an indicator of neoplastic grade: a pilot study.

Authors:  Dorota Pastuszak-Lewandoska; Anna Bartosińska-Dyc; Monika Migdalska-Sęk; Karolina H Czarnecka; Ewa Nawrot; Daria Domańska; Krzysztof Szyłło; Ewa Brzeziańska
Journal:  Med Oncol       Date:  2014-01-17       Impact factor: 3.064

6.  Expression of HPV-16 L1 capsomeres with glutathione-S-transferase as a fusion protein in tobacco plastids: an approach for a capsomere-based HPV vaccine.

Authors:  Syed Waqas Hassan; Mohammad Tahir Waheed; Martin Müller; Jihong Liu Clarke; Zabta Khan Shinwari; Andreas Günter Lössl
Journal:  Hum Vaccin Immunother       Date:  2014-11-19       Impact factor: 3.452

7.  Karyopherin beta3: a new cellular target for the HPV-16 E5 oncoprotein.

Authors:  Ewa Krawczyk; John A Hanover; Richard Schlegel; Frank A Suprynowicz
Journal:  Biochem Biophys Res Commun       Date:  2008-05-01       Impact factor: 3.575

8.  Multiplexed random peptide library and phospho-specific antibodies facilitate human polo-like kinase 1 inhibitor screen.

Authors:  Kenji Tanaka; Mitsunori Koresawa; Masato Iida; Kazuhiro Fukasawa; Erica Stec; Jason Cassaday; Peter Chase; Keith Rickert; Peter Hodder; Toshimitsu Takagi; Hideya Komatani
Journal:  Assay Drug Dev Technol       Date:  2010-02       Impact factor: 1.738

9.  Human papillomavirus type 16 P670 promoter is negatively regulated by CCAAT displacement protein.

Authors:  Kaori Sato; Takamasa Takeuchi; Iwao Kukimoto; Seiichiro Mori; Toshiharu Yasugi; Tetsu Yano; Yuji Taketani; Tadahito Kanda
Journal:  Virus Genes       Date:  2007-02-01       Impact factor: 2.332

10.  Characterization of immortalized human corneal endothelial cell line using HPV 16 E6/E7 on lyophilized human amniotic membrane.

Authors:  Hyun-Ju Kim; Yang-Hwan Ryu; Jae-Il Ahn; Jeong-Keuk Park; Jae-Chan Kim
Journal:  Korean J Ophthalmol       Date:  2006-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.